Fig. 7

PDL2+ DCs from skin-draining lymph nodes present antigen. a Percentage of CFSElowDO11.10 CD4+ T cells after co-culture with sorted PDL2+ (blue) or PDL2− (red) DCs from mice treated with OVA for 48 h. b Representative plots of the expression of LAP, CCR9, CCR6, and CCR4 by CFSE-low DO11.10 CD4+ T cells after co-culture with sorted PDL2+ DCs. Staining control is shown in grey (fluorescence minus one). c Percentage of CFSElow LAP+, CCR9+, CCR6+ or CCR4+ CD4+ T cells after co-culture with sorted PDL2+ (blue) or PDL2− (red) DCs from mice treated with OVA patch. N = 2−6 replicates. *p < 0.05, **p < 0.01, ****p < 0.0001 vs. PDL2-, Two-way Anova, Sidak’s multiple comparison test